IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances SOMN Q1 2026 Earnings Earnings Beat Estimates Amid Stable Operations FTNT Q1 2026 Earnings Massive EPS Beat of 302 Surprises Analysts Stock Edges Lower Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground NBN Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline Globus Medical Inc GMED Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gains